Bemitil for prevention of occupational hearing loss — patent RU2017483C1
L. A. Glaznikov, Iu. K. Revskoi, B. L. Makeev, V. R. Gofman, M. A. Nesterov · 1994 · Russian patent RU2017483C1; priority 1989
What does this source report?
The patent reports hearing loss at one year in 8/25 placebo recipients, 7/39 receiving a standard multi-agent regimen, and 5/84 receiving Bemitil. Filed 9 November 1989; published 15 August 1994.
- Population and setting
- 148 workers aged 22–24 exposed to aircraft-engine noise
- Evidence type
- Patent / reported experiments
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Random allocation, blinding, exposure comparability and attrition are not established by the patent.
- Patent claims are not equivalent to a peer-reviewed clinical trial or confirmed prevention.
- This does not replace hearing protection or occupational exposure controls.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Patent text and dates checked. The numerical comparison is attributed to the patent, not independently verified patient data.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: L. A. Glaznikov, Iu. K. Revskoi, B. L. Makeev, V. R. Gofman, M. A. Nesterov. Bemitil for prevention of occupational hearing loss — patent RU2017483C1 Russian patent RU2017483C1; priority 1989 1994.
Molekul research summary: https://molekul.io/research/acto-hearing-patent. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry